Feb 24, 2026Alcohol, Aging, and Long-Term Health: What the Evidence ShowsAlcohol consumption interacts with aging biology in complex ways. This article covers the liver, brain, cardiovascular, and cancer evidence, plus what nutritional strategies can mitigate harm.
Feb 20, 2026Liver Enzyme Elevation Risk: Silymarin, NAC, and Berberine With Lifestyle FirstElevated liver enzymes improve most with weight, glucose, and alcohol correction. Silymarin, NAC, and berberine can be adjuncts in selected metabolic-risk contexts.
Feb 16, 2026Phosphatidylcholine: Liver Health, Cognitive Aging, and Choline AdequacyPhosphatidylcholine is the dominant structural phospholipid in cell membranes and a major dietary choline source. It supports liver fat export, membrane integrity, and acetylcholine synthesis. Most adults are choline-insufficient; supplementation has meaningful implications for liver and brain aging.
Feb 15, 2026Silymarin (Milk Thistle): Liver Protection, MASLD Evidence, and Bioavailability ChallengesSilymarin (the active complex of milk thistle) has antioxidant and anti-inflammatory effects on hepatocytes. Evidence supports modest liver enzyme reduction in MASLD, though poor water solubility limits standard extract absorption. Phytosome forms show better bioavailability.
Jan 6, 2026NAC (N-Acetylcysteine): Glutathione Precursor, Liver Support, and Respiratory EvidenceNAC is the most established glutathione precursor supplement with strong evidence in clinical acetaminophen toxicity and COPD exacerbations. General longevity use has weaker but plausible support.